Psychiatry and Neurology, Neurology · Sugar Land, TX
NPI
1033399837
Since 2007
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
16605 Southwest Fwy, Suite 600
Sugar Land, TX, 77479
Phone (281) 494-6387
Groups this clinician bills Medicare through
Medicare paid, 2024
$274K
29,599 services
Medicare patients, 2024
465
Average age 75
Drug cost, 2024
$1.6M
3,583 prescriptions
Company payments, 2025
$35K
From 26 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Toby C Yaltho was code J0585 (injection, onabotulinumtoxina, 1 unit), 20,934 times for 31 patients. In total Toby C Yaltho billed 29,599 services in 45 codes, and Medicare paid $274K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-07-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 20,934 | 31 | $4.93 | $103K |
| J0587 Injection, rimabotulinumtoxinb, 100 units | Office | 880 | 11 | $10.22 | $8,991 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 431 | 308 | $12.53 | $5,403 |
| 99214 Office E&M - Established | Office | 413 | 292 | $82.26 | $34K |
| 99215 Office E&M - Established | Office | 306 | 211 | $126.06 | $39K |
| 95886 Electrical Nerve Conductivity | Office | 86 | 40 | $67.88 | $5,838 |
| 99213 Office E&M - Established | Office | 77 | 38 | $66.00 | $5,082 |
| 99205 Office E&M - New | Office | 64 | 64 | $143.75 | $9,200 |
| 64616 Musculoskeletal | Office | 47 | 16 | $133.74 | $6,286 |
| 64611 Musculoskeletal | Office | 40 | 14 | $88.71 | $3,548 |
| 64612 Musculoskeletal | Office | 40 | 14 | $120.52 | $4,821 |
| 95983 Electrical Nerve Conductivity | Office | 32 | 17 | $37.94 | $1,214 |
| 95970 Electrical Nerve Conductivity | Office | 23 | 15 | $13.03 | $300 |
| 95911 Electrical Nerve Conductivity | Office | 18 | 18 | $138.64 | $2,496 |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 14 | 14 | $24.87 | $348 |
By year: 2022 $261K for 23,247 services; 2023 $229K for 22,200 services; 2024 $274K for 29,599 services.
Medicare prescription drug claims, 2024
In 2024, the drug Toby C Yaltho prescribed most often to Medicare patients was Carbidopa-Levodopa (Carbidopa/Levodopa), with 713 prescriptions and refills. In total Toby C Yaltho wrote 3,583 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Carbidopa-Levodopa Carbidopa/Levodopa | 713 | 1,802 | 214 | $24K |
| Donepezil Hcl Generic | 238 | 580 | 73 | $5,351 |
| Memantine Hcl Generic | 196 | 399 | 47 | $5,814 |
| Primidone Generic | 192 | 456 | 56 | $11K |
| Rytary Carbidopa/Levodopa | 191 | 334 | 38 | $328K |
| Carbidopa-Levodopa Er Carbidopa/Levodopa | 188 | 426 | 55 | $10K |
| Propranolol Hcl Er Propranolol Hcl | 178 | 407 | 48 | $8,248 |
| Pramipexole Dihydrochloride Pramipexole Di-Hcl | 147 | 350 | 37 | $3,207 |
| Propranolol Hcl Generic | 145 | 398 | 52 | $4,076 |
| Rasagiline Mesylate Generic | 123 | 261 | 26 | $13K |
| Topiramate Generic | 116 | 242 | 30 | $1,810 |
| Clonazepam Generic | 87 | 117 | 18 | $585 |
| Ropinirole Hcl Generic | 67 | 163 | 15 | $1,047 |
| Gocovri Amantadine Hcl | 52 | 62 | Under 11 | $176K |
| Amantadine Amantadine Hcl | 51 | 83 | 13 | $2,252 |
Brand drugs: 479 claims; generic drugs: 3,104 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Toby C Yaltho $35K ($35K in general payments such as food, travel and fees) from 26 companies. The largest payer was Abbvie Inc. with $31K.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 72 | $31K |
| EMD Serono, Inc. MRK.DE | 14 | $334 |
| SK Life Science, Inc. | 10 | $295 |
| UCB, Inc. UCB.BR | 12 | $295 |
| Pfizer Inc. PFE | 20 | $265 |
| Novartis Pharmaceuticals Corporation NVS | 19 | $239 |
| Neurocrine BioSciences, Inc. NBIX | 10 | $233 |
| Argenx US, Inc. ARGX | 8 | $231 |
| Abbott Laboratories ABT | 5 | $219 |
| Amneal Pharmaceuticals LLC AMRX | 11 | $164 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.